Romania: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in Romania

The Romanian market for other medicaments for therapeutic or prophylactic uses surged to $X in 2022, rising by X% against the previous year. Overall, consumption, however, enjoyed a strong expansion. Over the period under review, the market attained the maximum level in 2022 and is expected to retain growth in years to come.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in Romania

In value terms, production of other medicaments for therapeutic or prophylactic uses soared to $X in 2022 estimated in export price. Over the period under review, production, however, continues to indicate resilient growth. The most prominent rate of growth was recorded in 2014 when the production volume increased by X%. Production of peaked in 2022 and is likely to continue growth in the near future.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from Romania

In 2022, shipments abroad of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the third consecutive year after six years of decline. Over the period under review, exports, however, continue to indicate a noticeable descent. The exports peaked at X tons in 2013; however, from 2014 to 2022, the exports failed to regain momentum.

In value terms, exports of other medicaments for therapeutic or prophylactic uses soared to $X in 2022. In general, exports saw temperate growth. The exports peaked at $X in 2013; however, from 2014 to 2022, the exports remained at a lower figure.

Exports by Country

Bulgaria (X tons), the Netherlands (X tons) and the United Arab Emirates (X tons) were the main destinations of exports of other medicaments for therapeutic or prophylactic uses from Romania, together accounting for X% of total exports.

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the main countries of destination, was attained by the United Arab Emirates (with a CAGR of X%), while the other leaders experienced more modest paces of growth.

In value terms, the Netherlands ($X) remains the key foreign market for other medicaments for therapeutic or prophylactic uses exports from Romania, comprising X% of total exports. The second position in the ranking was held by Hungary ($X), with an X% share of total exports. It was followed by Bulgaria, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value to the Netherlands amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Hungary (X% per year) and Bulgaria (X% per year).

Export Prices by Country

In 2022, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, declining by X% against the previous year. In general, the export price, however, recorded strong growth. The most prominent rate of growth was recorded in 2016 when the average export price increased by X% against the previous year. Over the period under review, the average export prices hit record highs at $X per ton in 2019; however, from 2020 to 2022, the export prices remained at a lower figure.

There were significant differences in the average prices for the major external markets. In 2022, amid the top suppliers, the country with the highest price was the Netherlands ($X,202 per ton), while the average price for exports to the United Arab Emirates ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the United Arab Emirates (X%), while the prices for the other major destinations experienced more modest paces of growth.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into Romania

In 2022, the amount of other medicaments for therapeutic or prophylactic uses imported into Romania rose sharply to X tons, growing by X% against 2021. In general, total imports indicated a tangible increase from 2012 to 2022: its volume increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, imports increased by X% against 2020 indices. The pace of growth appeared the most rapid in 2013 with an increase of X%. Over the period under review, imports of reached the maximum at X tons in 2019; however, from 2020 to 2022, imports remained at a lower figure.

In value terms, imports of other medicaments for therapeutic or prophylactic uses surged to $X in 2022. Overall, imports posted a buoyant increase. The pace of growth appeared the most rapid in 2021 when imports increased by X% against the previous year. Over the period under review, imports of reached the peak figure in 2022 and are likely to see steady growth in the immediate term.

Imports by Country

In 2022, Germany (X tons) constituted the largest other medicaments for therapeutic or prophylactic uses supplier to Romania, with a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from Germany exceeded the figures recorded by the second-largest supplier, Belgium (X tons), fourfold. The third position in this ranking was taken by Bulgaria (X tons), with an X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Germany amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Belgium (X% per year) and Bulgaria (X% per year).

In value terms, Bulgaria ($X) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to Romania, comprising X% of total imports. The second position in the ranking was held by Germany ($X), with an X% share of total imports. It was followed by China, with a X% share.

From 2012 to 2022, the average annual growth rate of value from Bulgaria stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: Germany (X% per year) and China (X% per year).

Import Prices by Country

In 2022, the average import price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, with an increase of X% against the previous year. In general, the import price posted temperate growth. The growth pace was the most rapid in 2020 when the average import price increased by X%. The import price peaked in 2022 and is expected to retain growth in years to come.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was the UK ($X per ton), while the price for Germany ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the UK (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :